The CONVERT Study: Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC)

Brief Description Of Study

This study is recruiting patients that have been diagnosed with a nontuberculous mycobacterial (NTM) lung infection that is caused by Mycobacterium avium complex (MAC; also known as MAI) and that have a history of failing to improve on standard treatments. MAC includes bacteria (germs) that are commonly found in the environment and can cause lung infections in predisposed people.

Clinical Study Identifier: TX1011

Detailed Study Description

The purpose of the study is to test the efficacy and safety of a medication that has not been approved for use in the treatment of NTM called Liposomal Amikacin for Inhalation (LAI), given once a day using a nebulizer in patients with lung infection due to MAC that has not previously been successfully treated. LAI will be administered in addition to standard therapy with other medications against lung infection called multi-drug therapy. The study is being conducted to learn the effects (good and bad) of the study drug LAI on you and your lung infection, test what the body does to the study drug, LAI and see if LAI improves your quality of life.

Additional Information About The Study

Eligibility Criteria • Be 18 years of age or older • Have an active lung infection caused by a specific group of bacteria (germs) called Mycobacterium avium Complex (MAC) and a history of failing to improve on treatment • Not be pregnant, trying to become pregnant, or nursing a baby. • Not have cystic fibrosis, active tuberculosis, or a history of lung transplant • Be willing to use specific medicine for the duration of the study • Meet all the requirements needed for participation in the study

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: The CONVERT Study: Liposomal Amikacin for Inhalation (LAI) in Adult Patients with Nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium avium complex (MAC)
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.